médicaments

Where are we in the race for the Covid-19 drug?

Where are we in the race for the Covid-19 drug?

Dominique Costagliola is Deputy Director of the Pierre-Louis Institute of Epidemiology and Public Health (Sorbonne University, Inserm). Member of the French Academy of Sciences, she is a member of the scientific board of the REACTing consortium. She gives an update on Covid-19 therapies still in the pipeline. The results of the studies that have been conducted

Plus
neem

Innovation in medicines: inspiration comes from nature

Morphine and codeine painkillers, taxol (anticancer), artemisinin (antimalarial) or aspirin... All these drugs have the particularity of having been discovered in plants or being derived from them. In fact, even today, as for millennia, the environment still provides us with most of the compounds that enable us to treat ourselves. To identify

Plus
gold nanoparticles

Gold nanoparticles to make medicines smarter

Scientists at the University of Lincoln in the United Kingdom have developed a new technique to coat gold nanoparticles with a specific protein so that they can be used to address a drug that will target a specific area of the body, such as a cancerous tumour, very precisely. Gold nanoparticles are

Plus
health and protection and HIV

Antibiotics, the shipwreck !

Santé immunitaire : la résistance aux antibiotiques tuent de plus en plus, selon le second ouvrage d’Antoine Andremont sur le sujet. Le 18 Novembre dernier c’était la « Journée Européenne sur les antibiotiques », une initiative du Centre Européen de Contrôle des Maladies pour faire comprendre que ces médicaments miracles

Plus

JOIN

THE CIRCLE OF THOSE WHO WANT TO UNDERSTAND OUR TIME OF TRANSITION, LOOK AT THE WORLD WITH OPEN EYES AND ACT

You have received 3 free articles to discover UP'.

Enjoy unlimited access to our content!

From $1.99 per week only.